Results 31 to 40 of about 1,103 (154)
Journal of Ocular Pharmacology and Therapeutics, 2011 This clinical trial evaluated the safety and effectiveness of bepotastine besilate ophthalmic solutions 1.0% and 1.5% compared with placebo for the treatment of ocular itching and conjunctival hyperemia (redness) using the conjunctival allergen challenge (CAC) model of allergic conjunctivitis when dosed 16 h before a CAC test.Subjects with a history of
Paul J. Gomes +6 more
core +3 more sources
Development of an Oral Gastroretnetive Formulation Containing Bepotastine Besilate
Journal of the Korea Academia-Industrial cooperation SocietySung-Hoon Lee
semanticscholar +2 more sources
Annals of Allergy, Asthma & Immunology, 2010 Bepotastine besilate is a selective histamine1-receptor antagonist and mast cell stabilizer with inhibitory effects on eosinophilic activity.To evaluate the safety and efficacy of 1.5% bepotastine besilate ophthalmic solution in alleviating nonocular symptoms induced by a conjunctival allergen challenge (CAC), a clinical model of allergic ...
Paul J. Gomes +5 more
core +3 more sources
Indian Journal of Dermatology, Venereology and Leprology, 2023 Background Urticaria is a common skin disease which often causes impairment in the quality of life. The ideal drug for chronic urticaria would have antihistaminic and anti-inflammatory actions.
E. Gayathri +3 more
semanticscholar +1 more source
JEADV Clinical Practice, Volume 2, Issue 2, Page 261-272, June 2023., 2023 Abstract Background Generalized pustular psoriasis (GPP) is a rare and often refractory disease, and GPP flares can be life threatening. The rarity of GPP prevents the development and evaluation of effective GPP‐specific treatments and obstructs disease understanding.
Akimichi Morita +12 more
wiley +1 more source
International journal of pharmaceutical sciences review and research, 2021 The aim of this study is to Evaluation of Efficacy and Safety of Bepotastine Besilate 0.15% Ophthalmic Solution in Patients of Vernal Keratoconjunctivitis (VKC). This was a prospective, open label and randomized clinical study.
J. Dahiya +3 more
semanticscholar +1 more source
Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
, 2023 Journal of Cutaneous Immunology and Allergy, Volume 6, Issue 2, Page 59-60, April 2023.
Mizuki Terada +3 more
wiley +1 more source
Renal Replacement Therapy, 2022 Background Severe pregabalin intoxication may cause serious symptoms, such as coma. Since pregabalin is a small molecule with no protein binding sites and has low volume of distribution, hemodialysis can be effective in eliminating pregabalin from the ...
Takashi Shimazui +8 more
doaj +1 more source
A prospective comparative study to evaluate the efficacy and safety of olopatadine eye drops and bepotastine eye drops in subjects of vernal kerato conjunctivitis [PDF]
, 2020 Background: Vernal keratoconjunctivitis (VKC) is an allergic eye disease that especially affects young boys. Both olopatadine and bepotestine are dual acting drugs that provide rapid symptomatic relief coupled with the long-term disease-modifying benefit.
Malahat, Amatur R. +2 more
core +1 more source